FDA Approves KYGEVVI®, the First and Only Treatment for Thymidine Kinase 2 deficiency (TK2d)

Thank You!

We've received your submission! Please check your inbox for a confirmation email that outlines a few next steps.

We look forward to connecting with you soon. For questions, please call us at 1-833-ASK-MDA1 (1-800-275-6321) or email us at ResourceCenter@mdausa.org.

In the meantime, check out all of the ways that MDA is here to support people living with neuromuscular disease and their families

Find MDA
in your Community